← Leaderboards
Maureen Joffe
Wits Health Consortium (Pty), Ltd
$759,247
Attributed
$3,700,743
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $474.8K · FY2015–24$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,700,743 · 2
By mechanism
R01$3,700,743 · 2
Top collaborators
- Judith S Jacobson11 shared
- Alfred I Neugut11 shared
- Paul Ruff11 shared
- Herbert Cubasch6 shared
- Wafaa M. El-Sadr6 shared
Most similar at Wits Health Consortium (Pty), Ltd
Same institution · by research overlap
- Paul Ruff$759,247
- Neil A Martinson$7,090,642
- Herbert Cubasch$331,878
- Michele Michele Ramsay$12,183,837
Others in their field
Top investigators on “Breast Cancer Patient”
- Norman Wolmark · Nsabp Foundation, Inc.$285,647,642
- Richard L Schilsky · University Of Chicago$123,229,424
- David Heimbrook · Leidos Biomedical Research, Inc.$116,623,736
- Walter John Curran · Thomas Jefferson University$116,287,499
- Monica M Bertagnolli · Strang Cancer Prevention Center$104,983,614
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$84,560,161
Research focus
Breast Cancer PatientWomanHospitalsUniversitiesFemaleResearch PersonnelSouth AfricaMalignant Breast NeoplasmMalignant NeoplasmsBreastCharacteristicsIncidenceInsightAfrica South Of The SaharaNewly DiagnosedCancer TherapyBreast Cancer TreatmentCessation Of LifeBreast Cancer DiagnosisClinicAntiretroviral TherapyCancer PatientEvidence Based GuidelinesAcademic Medical Centers
Grant awards (11)
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$345,761
R01 · FY2024 · CA · contact PI
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$347,160
R01 · FY2023 · CA · contact PI
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$124,999
R01 · FY2023 · CA · contact PI
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$348,517
R01 · FY2022 · CA · contact PI
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$474,837
R01 · FY2021 · CA · contact PI
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$349,996
R01 · FY2020 · CA · contact PI
HIV's Effects on Breast Cancer Treatment and Outcomes in South Africa$336,973
R01 · FY2019 · CA · contact PI
HIV's Effects on Breast Cancer Treatment and Outcomes in South Africa$342,373
R01 · FY2018 · CA · contact PI
HIV's Effects on Breast Cancer Treatment and Outcomes in South Africa$335,700
R01 · FY2017 · CA · contact PI
HIV's Effects on Breast Cancer Treatment and Outcomes in South Africa$344,783
R01 · FY2016 · CA · contact PI
HIV's Effects on Breast Cancer Treatment and Outcomes in South Africa$349,644
R01 · FY2015 · CA · contact PI